Erivedge may cause your advanced basal cell carcinoma to shrink, or it may help control your disease
In a clinical study, 104 adults took Erivedge for their advanced basal cell carcinoma. Of the 104 patients, 96 were evaluated for overall response rate (63 were diagnosed with locally advanced basal cell carcinoma and 33 were diagnosed with metastatic basal cell carcinoma).
27 of 63 patients with locally advanced basal cell carcinoma saw their tumor shrink at 24 weeks of treatment with Erivedge. Of those 27 patients, 13 saw no visible sign of basal cell carcinoma.
10 of 33 patients with metastatic basal cell carcinoma saw their tumor shrink at 24 weeks of treatment with Erivedge. No patients in this group saw their basal cell carcinoma completely disappear.
Questions to ask your doctor
Erivedge® (vismodegib) capsule is a prescription medicine used to treat adults with a type of skin cancer, called basal cell carcinoma, that has spread to other parts of the body or that has come back after surgery or that your healthcare provider decides cannot be treated with surgery or radiation.
It is not known if Erivedge is safe and effective in children.
Erivedge can cause your baby to die before it is born (be stillborn) or cause your baby to have severe birth defects.
There is a Pregnancy Exposure Registry for females taking Erivedge who become pregnant. The purpose of this registry is to monitor the health of you and your unborn baby. If you think that you or your female partner may have been exposed to Erivedge during pregnancy, talk to your healthcare provider right away. If you become pregnant during treatment with Erivedge, you or your healthcare provider should report your pregnancy to Genentech at (888) 835-2555.
Tell your healthcare provider right away if you develop any of the following signs or symptoms of a severe skin reaction, including:
Your healthcare provider may permanently stop Erivedge if you develop a severe skin reaction.
Erivedge can cause absence of menstrual periods (amenorrhea) in females who are able to become pregnant. It is not known if amenorrha is permanent. Talk to your healthcare provided if you have concerns about fertility.
These are not all of the possible side effects of Erivedge. Because everyone is different, it is not possible to predict what side effects any one person will have or how severe they may be. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
Please see full Prescribing Information for additional Important Safety Information, including serious side effects, and the Medication Guide.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.